RSS   Newsletter   Contact   Advertise with us
Post Online Media

Obalon Therapeutics adds David Moatazedi to board

David MoatazediObalon Therapeutics, a biotechnology company, announced that David Moatazedi has been appointed to its board of directors.
Article continues below

READ MORE Silence Therapeutics appoints David Ellam as CFO

Mr. Moatazedi is currently the Senior Vice President, US Medical Aesthetics for Allergan plc.

In this role, Mr. Moatazedi is a member of the Allergan Commercial Leadership Team with multiple business unit responsibility, including Facial Aesthetics, Plastics and Regenerative Medicine and Skincare.

Mr. Moatazedi has over seventeen years’ commercial experience managing upstream and downstream marketing, working across multiple brands with increasing responsibility.

He has also led several business units as Vice President, Sales and Marketing beginning with Plastic Surgery and followed by Facial Aesthetics.



We use cookies to ensure that we give you the best experience on our website. Please allow cookies for fully-functioning website.

Allow Cookies Privacy Policy